Risk factors

Zenas BioPharma (ZBIO) risk factors

Item 1A of every Zenas BioPharma, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open ZBIO in Gloom →
Zenas BioPharma's chart, financials and news, free in your browser.Open ZBIO in Gloom →
  • FY2025 10-K risk factors
    76 risks10 new11 dropped16 reworded

    Zenas BioPharma faces a going concern doubt after reporting recurring operating losses through December 31, 2025., The company secured up to a $250.0 million term loan agreement with Pharmakon funds in March 2026, which requires significant cash servicing., A securities class action lawsuit was filed in April 2025 against the company, its directors, and IPO underwriters.

    Filed Mar 16, 2026
  • FY2024 10-K risk factors
    77 risks

    Zenas BioPharma faces significant risks typical of clinical-stage biotechs without approved products or revenue.

    Filed Mar 11, 2025